Julphar, one of the biggest pharmaceutical companies in the Middle East and Africa, is embarking on an ambitious turnaround strategy. Jeff Topping / The National
Julphar, one of the biggest pharmaceutical companies in the Middle East and Africa, is embarking on an ambitious turnaround strategy. Jeff Topping / The National

Markets

Julphar shareholders approve restructuring plan through rights issue

The troubled drug maker now aims to re-enter Saudi Arabia and Kuwait

Sarmad Khan
Sarmad Khan

April 12, 2020